Tech Company Financing Transactions
Pencil Biosciences Funding Round
Pencil Biosciences closed a $6.8 million Seed investment round on 9/28/2023. Investors included Catapult Ventures, Greater Manchester Combined Authority and private investors.
Transaction Overview
Company Name
Announced On
9/28/2023
Transaction Type
Venture Equity
Amount
$6,830,000
Round
Seed
Investors
Proceeds Purpose
The company will use the funds to develop its non-CRISPR gene editing platform for rare diseases and cancer treatments. .
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Office 3rd Floor 38, Mereside Alderley Park
Macclesfield, England, SK10 4TG
UK
Macclesfield, England, SK10 4TG
UK
Phone
Undisclosed
Website
Email Address
Overview
Developer of gene-editing technology designed to create a range of applications like new therapeutic options for patients with rare diseases. The company's technology develops a novel genome modulation platform that helps to anticipate a wide impact across a range of applications, enabling medical professionals to overcome the challenges of gene editing associated with various technologies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Amanda Smith
Co-Founder
Rajik Ibrahim
Browse more venture capital transactions:
Prev: 9/28/2023: Partum Health venture capital transaction
Next: 9/28/2023: AlphaSense venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on all VC transactions involving tech companies. All VC database entries on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs